文献速递重症综合管理与镇静镇痛

SOFA 2 评分的外部验证:一项中国回顾性队列研究

External validation of SOFA 2 score: a retrospective Chinese cohort study.
PubMed 文献 · Ann Intensive Care · 2026-06-25
一句话结论在中国多中心ICU队列中,SOFA-2对ICU死亡的判别优于SOFA-1(AUROC 80.9% vs 76.7%)。

该回顾性多中心研究纳入2014至2024年118,542例成人ICU患者,用入住ICU前7天临床数据计算SOFA-1与SOFA-2评分,主要终点为ICU死亡。ICU死亡5,286例(4.45%),住院死亡6,173例(5.2%)。SOFA-2对ICU死亡的AUROC为80.9%(95%CI 80.3%-81.5%),显著优于SOFA-1的76.7%(95%CI 76.0%-77.4%);SOFA-2每增加1分,ICU死亡OR为1.33(95%CI 1.33-1.35)。SOFA-2队列间方差更低(0.07 vs 0.23),提示跨中心更稳健,支持其在资源受限环境中的更广泛适用性。

要点

  • 在中国118,542例成人ICU患者中,SOFA-2对ICU死亡的判别优于SOFA-1(AUROC 80.9% vs 76.7%)。
  • SOFA-2总分每增加1分,ICU死亡风险OR为1.33(95%CI 1.33-1.35)。
  • SOFA-2各器官亚评分(0-4分)与总分越高,ICU死亡频率越高。
  • SOFA-2队列间方差为0.07,低于SOFA-1的0.23,提示跨中心分布更一致。
  • 入住ICU前7天内,存活者与死亡者的SOFA-2轨迹差异随时间扩大。

适用人群与场景

  • 2014至2024年间入住ICU的成人患者,来自多中心中国队列,共118,542例。
  • 研究关注资源受限环境下数据不完整时的评分表现。

诊断标准与关键阈值

  • 使用入住ICU前7天临床数据计算SOFA-1与SOFA-2评分(总分及各器官亚评分0-4分)。
  • 主要终点为ICU死亡;采用多种方法处理缺失数据。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 回顾性多中心队列研究,纳入118,542例成人ICU患者,ICU死亡5,286例(4.45%),住院死亡6,173例(5.2%)。
  • SOFA-2对ICU死亡的AUROC为80.9%(95%CI 80.3%-81.5%),SOFA-1为76.7%(95%CI 76.0%-77.4%)。
  • SOFA-2每增加1分,ICU死亡OR为1.33(95%CI 1.33-1.35)。
  • SOFA-2队列间方差为0.07,SOFA-1为0.23。
  • 前7天SOFA-2轨迹在存活者与死亡者间差异逐渐扩大。

证据类型、等级与局限

  • 证据类型:回顾性多中心队列研究(外部验证)。
  • 局限:回顾性设计;原文未给出证据等级或推荐强度;原文提及采用多种方法处理缺失数据。

对床旁实践的改变

  • 在资源受限、数据可能不完整的ICU环境中,SOFA-2较SOFA-1对ICU死亡具有更好的判别力,可考虑用于早期识别急性器官功能障碍。
  • SOFA-2跨中心分布更一致,支持其在不同医疗环境中的更广泛适用性。
  • 原文未提及具体评分 cutoff 或治疗调整方案,不能据此推导临床决策阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: The revised Sequential Organ Failure Assessment (SOFA) 2 score was developed to improve early identification of acute organ dysfunction, which restricted from incomplete data in resource-limited settings. To compare the performance of original (SOFA-1) and updated SOFA-2 scores in these settings.

METHODS: The retrospective multicenter analysis included 118,542 adult patients admitted to intensive care units (ICUs) between 2014 and 2024. SOFA scores were calculated using clinical data from the first seven ICU days. The primary outcome was ICU mortality. Multiple approaches were applied to address missing data. We assessed the discriminative performance of total SOFA and organ-specific scores using the area under the receiver operating characteristic curve (AUROC).

RESULTS: A total of 5,286 patients (4.45%) died in the ICU, and 6,173 patients (5.2%) died during hospitalization. Across all cohorts, higher SOFA-2 subscores (0-4) and total scores were associated with lower frequency and higher ICU mortality. SOFA-2 demonstrated significantly better discrimination for ICU mortality than SOFA-1 [AUROC of 80.9% (95% CI, 80.3%-81.5%) vs. 76.7% (95% CI, 76.0%-77.4%)]. Each 1-point increase in SOFA-2 was associated with increasing odds of ICU mortality (OR 1.33, 95% CI 1.33-1.35). Between-cohort variance was lower for SOFA-2 (0.07) than for SOFA-1 (0.23), indicating greater robustness across these cohorts. Longitudinal analyses showed widening divergence in SOFA-2 trajectories between survivors and non-survivors over the first 7 days.

CONCLUSION: In this external validation, SOFA-2 demonstrated improved discrimination for ICU mortality and more consistent score distribution than SOFA-1. These findings support the broader applicability of SOFA-2 across diverse healthcare settings, including those with substantial resource constraints.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Liufu R, Cao M, Shi XQ, et al. External validation of SOFA 2 score: a retrospective Chinese cohort study. Ann Intensive Care. 2026. PMID: 42434601. doi:10.1016/j.aicoj.2026.100107

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。